DeBoer [4] considered the evidence linking systemic inflammation to CVD risk in adults to be stronger than that relating to insulin resistance and T2DM but commented that long-term data linking increased hs-CRP levels—and increased insulin or decreased adiponectin—in childhood to adult disease outcomes are currently lacking. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.